Anacail Limited, a spin-out from the University of Glasgow’s School of Physics and Astronomy, closed a £2m Series A equity funding.
Backers included new investor Sussex Place Ventures, existing investors IP Group plc and the Scottish Investment Bank (SIB) as well as a some private individuals.
Led by Ian Muirhead, Chief Executive Officer, and Gareth Voyle, Non Executive Chairman, Anacail specializes in creating and handling ozone in flexible ways. Its technology allows the generation of ozone (an activated form of oxygen), inside sealed packages, without damaging or opening the package. The ozone, generated from oxygen inside the package, is a potent germicide and, after a short time, all the ozone decays back to oxygen, leaving no residual chemicals, and a decontaminated or sterilized package and contents.
The initial target market for the technology is in food decontamination across the supply chain.
Anacail was also awarded a £300k Innovate UK Biomedical Catalyst grant, in partnership with the University of Glasgow, to develop its application of ozone in medical device sterilization and decontamination.